(NASDAQ: AMED) Amedisys's forecast annual revenue growth rate of 10.74% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 9.89%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.2%.
Amedisys's revenue in 2023 is $2,220,452,000.On average, 10 Wall Street analysts forecast AMED's revenue for 2023 to be $81,692,363,481, with the lowest AMED revenue forecast at $78,269,949,893, and the highest AMED revenue forecast at $85,104,964,489. On average, 5 Wall Street analysts forecast AMED's revenue for 2024 to be $89,701,346,095, with the lowest AMED revenue forecast at $86,347,458,110, and the highest AMED revenue forecast at $91,513,359,282.
In 2025, AMED is forecast to generate $98,265,519,308 in revenue, with the lowest revenue forecast at $98,265,519,308 and the highest revenue forecast at $98,265,519,308.